ABBOTT LABORATORIES — Director's Dealing 2011

Feb 23, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-02-18

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-18	Common shares without par value	A	61300	—	Acquired	427779	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-18	Option (right to buy)	$46.60	A	86300	Acquired	2021-02-17	Common shares (86300)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	992	Indirect
Common shares without par value	15000	Indirect
Common shares without par value	1941	Indirect
Common shares without par value	1941	Indirect
Common shares without par value	1941	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2011.

F3: Held in the Annette Newton-Freyman 1994 Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.

F4: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons.

F5: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 28,767 on 02/18/2012, 28,766 on 02/18/2013, and 28,767 on 02/18/2014.